Sort by
Items per page

Send to

Choose Destination

Links from UniGene

Items: 8


A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.

Li L, Wang XH, Williams C, Volsky B, Steczko O, Seaman MS, Luthra K, Nyambi P, Nadas A, Giudicelli V, Lefranc MP, Zolla-Pazner S, Gorny MK.

Mol Immunol. 2015 Aug;66(2):364-74. doi: 10.1016/j.molimm.2015.04.011. Epub 2015 May 18.


Human paralogs of KIAA0187 were created through independent pericentromeric-directed and chromosome-specific duplication mechanisms.

Crosier M, Viggiano L, Guy J, Misceo D, Stones R, Wei W, Hearn T, Ventura M, Archidiacono N, Rocchi M, Jackson MS.

Genome Res. 2002 Jan;12(1):67-80.


Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.

Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, Kramer RA, Clijsters-van der Horst M, de Jong M, Jongeneelen M, Thijsse S, Smit R, Visser TJ, Bijl N, Marissen WE, Loeb M, Kelvin DJ, Preiser W, ter Meulen J, de Kruif J.

J Virol. 2006 Jul;80(14):6982-92.


Genetic origin of IgG antibodies cloned by phage display and anti-idiotypic panning from three patients with autoimmune thrombocytopenia.

Jendreyko N, Uttenreuther-Fischer MM, Lerch H, Gaedicke G, Fischer P.

Eur J Immunol. 1998 Dec;28(12):4236-47.


Thyroid peroxidase autoantibodies obtained from random single chain FV libraries contain the same heavy/light chain combinations as occur in vivo.

Chapal N, Chardès T, Bresson D, Pugnière M, Mani JC, Pau B, Bouanani M, Péraldi-Roux S.

Endocrinology. 2001 Nov;142(11):4740-50.


One-megabase sequence analysis of the human immunoglobulin lambda gene locus.

Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL, Wang J, Shimizu N.

Genome Res. 1997 Mar;7(3):250-61.


Novel expressed sequences identified in a model of androgen independent prostate cancer.

Quayle SN, Hare H, Delaney AD, Hirst M, Hwang D, Schein JE, Jones SJ, Marra MA, Sadar MD.

BMC Genomics. 2007 Jan 26;8:32.

Supplemental Content

Support Center